7 Trusted Experts to Follow for GLP-1 Guidance

Rocio Salas-Whalen, MD is a New York–based, board-certified physician specializing in obesity medicine and endocrinology who’s especially good at making GLP-1s feel less confusing.

On social media, she talks about topics such as how these meds work for women, what changes with PCOS or insulin resistance and what to expect as treatment progresses. She regularly flags GLP-1 news as it happens, and explains what’s worth paying attention to (and what isn’t).

She’s also the author of Weightless, A Doctor’s Guide to GLP-1 Medications, Sustainable Weight Loss and the Health You Deserve.

Amanda Kahn, MD is a New York–based, board-certified internist and longevity specialist who approaches GLP-1s through a long-term health lens. Instead of focusing solely on weight, she talks about energy levels, metabolic health, body composition and what long-term use of GLP-1 medications can realistically look like.

Follow Dr. Franco For: A realistic take on the aesthetic changes that can come with significant weight loss.

While most of board-certified facial plastic surgeon Kay Durairaj, MD’s content centers on aesthetic treatments—often offering a behind-the-scenes look at what patients can expect during appointments—she occasionally addresses the intersection of aesthetics and GLP-1 medications. When she does, it’s usually to explain terms like “Ozempic face” and other weight-loss–related facial changes, including shifts in volume or skin quality that can occur with rapid weight loss, as well as how those concerns are treated.

Follow Dr. Duraraij For: No-nonsense education on facial structure, aesthetic treatments and weight-loss–related facial changes.

You’ll often hear from Boston-based obesity medicine physician, scientist, educator and policy maker Fatima Cody Stanford, MD in the media and on podcasts, but she also regularly shares insight on Instagram.

She’s who people turn to when the GLP-1 conversation starts to feel a little too glossy. Dr. Stanford talks openly about the realities that don’t always make it into viral posts, such as how unpredictable insurance coverage can be, why cost remains such a major barrier and what happens when people have to stop these medications.

She also stresses that GLP-1s aren’t a quick fix or a one-size-fits-all solution, and that treating obesity as a chronic condition means thinking long term.